Regencell Bioscience Holdings Ltd
RGC
Market Cap$56.61M
Close$
$0.22
100% downside
Current Fair Value
100% downsideOvervalued by 100% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $56.61 Million |
|---|---|
| Enterprise Value | $53.70 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.45 |
| Beta | -0.58 |
| Outstanding Shares | 13,012,866 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -12.02 |
|---|---|
| PEG | 77.77 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.08 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data